367 related articles for article (PubMed ID: 21178275)
1. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
Blundell MP; Worth A; Bouma G; Thrasher AJ
Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
Ochs HD
Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
[TBL] [Abstract][Full Text] [Related]
3. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding.
Massaad MJ; Ramesh N; Le Bras S; Giliani S; Notarangelo LD; Al-Herz W; Notarangelo LD; Geha RS
J Allergy Clin Immunol; 2011 Apr; 127(4):998-1005.e1-2. PubMed ID: 21376381
[TBL] [Abstract][Full Text] [Related]
4. New insights into the biology of Wiskott-Aldrich syndrome (WAS).
Thrasher AJ
Hematology Am Soc Hematol Educ Program; 2009; ():132-8. PubMed ID: 20008191
[TBL] [Abstract][Full Text] [Related]
5. Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state.
Stabile H; Carlino C; Mazza C; Giliani S; Morrone S; Notarangelo LD; Notarangelo LD; Santoni A; Gismondi A
Blood; 2010 Apr; 115(14):2818-26. PubMed ID: 20130240
[TBL] [Abstract][Full Text] [Related]
6. WASP: a key immunological multitasker.
Thrasher AJ; Burns SO
Nat Rev Immunol; 2010 Mar; 10(3):182-92. PubMed ID: 20182458
[TBL] [Abstract][Full Text] [Related]
7. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.
Liu DW; Zhang ZY; Zhao Q; Jiang LP; Liu W; Tu WW; Song WX; Zhao XD
Pediatr Blood Cancer; 2015 Sep; 62(9):1601-8. PubMed ID: 25931402
[TBL] [Abstract][Full Text] [Related]
8. Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation.
Notarangelo LD; Ochs HD
Curr Opin Immunol; 2003 Oct; 15(5):585-91. PubMed ID: 14499269
[TBL] [Abstract][Full Text] [Related]
9. WIP remodeling actin behind the scenes: how WIP reshapes immune and other functions.
Noy E; Fried S; Matalon O; Barda-Saad M
Int J Mol Sci; 2012; 13(6):7629-7647. PubMed ID: 22837718
[TBL] [Abstract][Full Text] [Related]
10. The Wiskott-Aldrich syndrome.
Ochs HD; Thrasher AJ
J Allergy Clin Immunol; 2006 Apr; 117(4):725-38; quiz 739. PubMed ID: 16630926
[TBL] [Abstract][Full Text] [Related]
11. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
[TBL] [Abstract][Full Text] [Related]
12. Wiskott-Aldrich syndrome: a disorder of haematopoietic cytoskeletal regulation.
Thrasher AJ; Burns S
Microsc Res Tech; 1999 Oct; 47(2):107-13. PubMed ID: 10523789
[TBL] [Abstract][Full Text] [Related]
13. The role of WASp in T cells and B cells.
Sun X; Wei Y; Lee PP; Ren B; Liu C
Cell Immunol; 2019 Jul; 341():103919. PubMed ID: 31047647
[TBL] [Abstract][Full Text] [Related]
14. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome.
Facchetti F; Blanzuoli L; Vermi W; Notarangelo LD; Giliani S; Fiorini M; Fasth A; Stewart DM; Nelson DL
J Pathol; 1998 May; 185(1):99-107. PubMed ID: 9713366
[TBL] [Abstract][Full Text] [Related]
15. Novel WASP mutation in a patient with Wiskott-Aldrich syndrome: Case report and review of the literature.
Eghbali M; Sadeghi-Shabestari M; Najmi Varzaneh F; Zare Bidoki A; Rezaei N
Allergol Immunopathol (Madr); 2016; 44(5):450-4. PubMed ID: 26993433
[TBL] [Abstract][Full Text] [Related]
16. [Wiskott-Aldrich syndrome].
Gulácsy V; Maródi L
Orv Hetil; 2008 Jul; 149(29):1367-71. PubMed ID: 18617469
[TBL] [Abstract][Full Text] [Related]
17. The Wiskott-Aldrich syndrome: disordered actin dynamics in haematopoietic cells.
Thrasher AJ; Burns S; Lorenzi R; Jones GE
Immunol Rev; 2000 Dec; 178():118-28. PubMed ID: 11213796
[TBL] [Abstract][Full Text] [Related]
18. Macrophages of patients with X-linked thrombocytopenia display an attenuated Wiskott-Aldrich syndrome phenotype.
Linder S; Wintergerst U; Bender-Götze C; Schwarz K; Pannicke U; Aepfelbacher M
Immunol Cell Biol; 2003 Apr; 81(2):130-6. PubMed ID: 12631236
[TBL] [Abstract][Full Text] [Related]
19. Wiskott-Aldrich syndrome: a comprehensive review.
Massaad MJ; Ramesh N; Geha RS
Ann N Y Acad Sci; 2013 May; 1285():26-43. PubMed ID: 23527602
[TBL] [Abstract][Full Text] [Related]
20. Wiskott-Aldrich syndrome.
Notarangelo LD; Miao CH; Ochs HD
Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
